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ABSTRACT
The paper discusses the difficulties in judging the quality of scientific manuscripts
and describes some common pitfalls that should be avoided when preparing a paper
for submission to a peer-reviewed journal. Peer review is an imperfect system, with
less than optimal reliability and uncertain validity. However, as it is likely that it will
remain as the principal process of screening papers for publication, authors should
avoid some common mistakes when preparing a report based on empirical findings
of human research. Among these are: excessively long abstracts, extensive use of
abbreviations, failure to report results of parsimonious data analyses, and
misinterpretation of statistical associations identified in observational studies as causal.
Another common problem in many manuscripts is their excessive length, which
makes them more difficult to be evaluated or read by the intended readers, if published.
The evaluation of papers after their publication with a view towards their inclusion in
a systematic review is also discussed. The limitations of the impact factor as a criterion
to judge the quality of a paper are reviewed.
KEYWORDS: Editorial policies. Peer review, research. Evaluation,
standards. Publications, standards. Scientific publications.
RESUMO
O artigo discute as dificuldades em julgar a qualidade de manuscritos científicos e
descreve algumas das armadilhas comuns que devem ser evitadas ao preparar um
artigo para submissão a um periódico. A revisão por pares é um sistema imperfeito,
com confiabilidade abaixo da ideal e validade duvidosa. Entretanto, como
provavelmente continuará sendo o principal processo de seleção de artigos para
publicação, os autores devem evitar alguns erros ao preparar um manuscrito baseado
em achados empíricos da pesquisa humana. Entre eles estão: resumos excessivamente
longos, amplo uso de abreviações, falha ao relatar resultados de análise de dados
parcimoniosa, e interpretação equivocada de associações estatísticas encontradas em
estudos observacionais como sendo causais. Outro problema comum em muitos
manuscritos é sua excessiva extensão, o que os torna mais difíceis de serem avaliados
ou lidos por leitores-alvo, se publicados. Discute-se a avaliação de artigos após sua
publicação e inclusão em revisão sistemática. São revisadas as limitações do fator de
impacto como um critério para julgar a qualidade de um artigo.
DESCRITORES: Políticas editoriais. Pesquisa avaliada pelos pares.
Avaliação, normas. Publicações, normas. Publicações científicas.
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INTRODUCTION
In 1731, the Royal Society of Edinburgh stated that
“Memoirs sent by correspondence are distributed... to
those members who are most versed in these matters...
Nothing is printed in the review which is not stamped
with the mark of utility.”11 Thus, the peer review proc-
ess – which represents the main approach to evaluate
the quality of scientific publications – is not recent,
even though it was fairly rare until after the Second
World War, when the increasing number of papers sub-
mitted to journals and the increasing specialization of
science made it virtually mandatory.5
According to Lock,10 a former editor of the British
Medical Journal, peer review has three main objec-
tives: prevent publication of bad work, improve schol-
arship, and improve language and data presentation.
That these objectives are probably not being thor-
oughly met has been known for some time. For exam-
ple, Yankauer,21 a former editor-in-chief of the Ameri-
can Journal of Public Health (AJPH) found out that
61 of 72 papers submitted to that journal had been
submitted initially to other journals; however, only
1/3 of these had been revised substantially prior to
submission to the AJPH. This finding was consistent
with that of other study showing that, of the 70-85%
of papers rejected by the British Medical Journal,
only 20% were changed substantially before submis-
sion to a different journal.11 In addition, it appears
that a large proportion of published articles are never
used as reference after publication.11,20 Thus, the ex-
tent to which peer review is achieving an improve-
ment in scholarship is open to question.
The objectives of peer review proposed by Lock10
suggest a conceptual framework within which qual-
ity of articles might be judged. Thus, the two main
questions that outside experts and editors must ask
when reviewing a scientific paper are: (a) Does the
research on which the manuscript is based advance
scientific knowledge? and, (b) Is the report clearly
written? Not always the answers to these questions
converge. When the study seems to advance knowl-
edge notwithstanding problems with the report’s data
presentation and language, it may well be salvage-
able, in which case the editor defers the decision on
acceptability pending the necessary revisions. On the
other hand, a negative answer to the first question
makes the second moot, as it implies that the paper
should be rejected (Table).
HOW TO JUDGE QUALITY
How can the quality of a paper be judged, and which
are the “risk factors” for a paper lacking in quality?
Assessment of quality remains elusive. In the Ameri-
can Journal of Epidemiology, for example, quality
items typically include originality, design, conclu-
sions, importance/interest, presentation, and docu-
mentation. However, the reviewer is not given instruc-
tions as to how these should be assessed. Each of
these items is assigned to an “excellent”, “very good”,
“satisfactory” or “poor” category. On the basis of this
classification, which also includes an overall category
(“overall quality”), the editor decides to accept with
routine copy editing, accept with only minor revi-
sions, defer the decision because the paper is cur-
rently unacceptable (with an indication as to whether
or not the paper is likely to become acceptable after
major revisions), or reject the paper.
Although in most peer reviewed journals in the pub-
lic health area the instructions to reviewers are as
relatively nonspecific as those from the American
Journal of Epidemiology, some authors have tried to
quantify quality in a more systematic fashion. An
example is Chalmers et al6 scoring system for evalu-
ating the quality of a clinical trial, which is based on
an assessment of both internal validity items address-
ing comparability (e.g., analysis of efficacy of rand-
omization, blinding in evaluating outcomes, com-
pliance), and external validity items related to the
generalizability of findings (e.g., study population
characteristics, list of eligible but not enrolled indi-
viduals, discussion of side effects). Basically, how-
ever, peer review remains a process with imperfect
reliability and undetermined validity.2,8,14,16
Systematic reviews are noteworthy – as well as its
quantitative expression, meta-analysis – as instru-
ments for evidence-based medicine and public health,4
given their increasing popularity and because their
analytic unit is study (rather than individual). Thus,
it is also important to judge the quality of papers
after they are published. One of the ways in which
quality of papers should not be judged after publica-
tion is by use of the citation indexes of the journals
Table - Usual editorial decisions according to characteristics of an article submitted to a reputable peer-reviewed journal.
Study improves Report  is clearly and Usual editorial decision
scholarship accurately written
No No Rejection
No Yes Rejection
Yes No Deferral
Yes Yes Acceptance
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in which they were published. In a recent study by
Berghmans et al,3 for example, a very weak associa-
tion was found between the quality of lung cancer
randomized clinical trials and these indexes, which
included the impact factor.* A similar conclusion was
reached by Barbui et al1 with regard to trials related
to an antidepressant. Because it is a common practice
to use the impact factor as a marker of quality of arti-
cles in certain academic settings, particularly in some
European countries (where it can be used when con-
sidering the promotion of a faculty member to a higher
rank), it is useful to list some important conceptual
and technical flaws inherent to this index:20
1. the number of journals in the Institute for
Scientif ic Information, which estimates the
impact factor, is a small proportion of those
published;
2. literature reviews are cited more often than results
of single empirical studies, thus favoring journals
that publish reviews frequently or exclusively;
3. the impact factor does not take self-citations into
consideration;
4. the accuracy of the assumption of a positive link
between citations and quality is questionable, as
papers can, for example, be cited because they are
based on flawed studies.
“RISK FACTORS” FOR POOR QUALITY OF
EPIDEMIOLOGIC MANUSCRIPTS
It is possible to follow some simple rules and avoid
some pitfalls that may decrease the likelihood of ac-
ceptance of a paper. The discussion that follows is not
meant to convey rigid guidelines, but merely point
out some ways to improve a paper’s quality based on
this author’s experience with common avoidable mis-
takes detected over the years in papers submitted to
the American Journal of Epidemiology.
Assuming that the research findings being reported
are sound, one of the key objectives of a scientific
paper is that the rationale, design, findings and infer-
ences from the study results be clearly conveyed and
understood by the intended readers. Therefore, one
of the quality issues that authors should keep in mind
when writing their papers is, What is the target audi-
ence for whom the publication is intended? Epide-
miologists? Other public health practitioners? Policy
makers? Practicing physicians? Each type of reader
requires a different approach to reporting study find-
ings. As a general strategy, however, it is highly rec-
ommended that the language used be both simple
and unambiguous. Technical terms should be ex-
plained and abbreviations avoided, with a few possi-
ble exceptions represented by well known abbrevia-
tions, such as HIV or EKG. Consider, for example, the
following sentence, which is difficult to understand
in view of the large number of abbreviations: The US-
determined IMT of participants with AP showed a
strong correlation with ABI. Patients with low ABI
also had a high CRP. When properly modified, the
sentence should read, The B-mode ultrasound-deter-
mined intimal-medial thickness of the carotid arter-
ies in participants with angina pectoris showed a
strong correlation with ankle-brachial index. Pa-
tients with low ankle-brachial index also had a high
level of C-reactive protein.
It should be also strongly emphasized that, even
within the length allowed by the journal to which the
paper is submitted, the paper should be as short as
possible, as a short paper not only makes the journal
more reader-friendly, but also eases the burden on
reviewers and editors.18 The preparation of a short
(rather than a long) report is a difficult task that may
require a considerable time investment, as highlighted
by a reputed letter from Mark Twain to a friend: Dear
friend: I am sorry I had to write you such a long
letter. I did not have time to write you a short one…
Using the format favored by most epidemiologists and
empirical researchers in the biomedical field since the
1970s15 (IMRAD, or – in addition to the abstract –
“Introduction”, “Methods”, “Results” and “Discus-
sion”), the following pitfalls should be avoided:
Abstract
The abstract is often the only part that is read. It should
be used as a way to encourage the potential reader to
read the whole paper. Abstracts should state findings
and conclusions, not only the purpose of the study
(as done often in abstracts sent in advance of a meet-
ing’s oral presentation). Thus, “Results will be pre-
sented…” is not allowed in abstracts of manuscripts
submitted to a peer-reviewed journal for considera-
tion for publication. Abstracts are of poor quality if
they are long, use abbreviations and acronyms, and
include redundant information, such as both confi-
dence limits and standard errors.
Introduction
The Introduction is the section where the study’s justi-
fication and statement of hypotheses belong. It should
contain an extensive review of the literature, but rather
a review of scientific findings that are relevant to the
study hypotheses. In a biomedical and public health
*Defined by Garfield7 as the number of citations to the articles published in a given journal during the two preceding years, divided by the
number of articles published in that journal within the same period.
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paper, it is often necessary to state the plausibility of
the hypothesis (biologic, sociologic, and others). It
should be also clearly stated whether an observed in-
teraction was an a priori hypothesis, rather than a re-
sult of subgroup analysis. Authors should in addition
describe the main reason why the study was carried
out: to test a new hypothesis (or hypotheses); to con-
firm a previously tested hypothesis when replication
is necessary; or to examine a previously tested hy-
pothesis using a new design or methodology that is
superior to those used in previous studies.
Methods
Methods is a key section, as it allows the reviewers and
the editor – and, if the paper is published, the readers –
to judge the soundness of the study design and the
analytic strategies. In order to evaluate the level of the
study’s external validity (generalizability), the study
population should be described in detail; inclusion
and exclusion criteria should be specified. A descrip-
tion of the study variables and confounders, including
the categories chosen and the criteria to select them
should be provided (e.g., based on traditional catego-
rization such as ages 45-49, 50-54 and so on, or for
continuous variables, use of percentile values, such as
the median or quartiles). The approach to identify
confounders and effect modifiers should also be de-
scribed. Whereas the former is usually based on either
previous literature or assessment of study data, the lat-
ter is a function of the biologic (or other) plausibility
of the hypothesis. As mentioned previously here, if
subgroup analyses are carried out and interaction(s)
were not part of the a priori hypothesis, specification
of these analyses as exploratory is necessary.
Data collection procedures must be described in de-
tail. If the study was questionnaire or inventory-based,
the authors should offer to publish the instrument
online (provided that there are no copyright issues).
Quality assurance – which includes training of data
collectors – and quality control measures should be
described. The latter include observation monitor-
ing, studies of replicate samples using phantoms, and
estimation of validity and reliability indexes, such
as sensitivity, specificity, kappa and intra-class cor-
relation coefficient.
Analytic approaches should be as parsimonious as
possible. For example, for case-control data, if only a
few variables have to be adjusted for, it may not be
necessary to use logistic regression (unless these vari-
ables are continuous). A simpler method, such as the
Mantel-Haenzsel technique to adjust for odds ratios,
may be sufficient.
When assessing interactions, most authors choose
the interaction model as a function of the regression
model used for adjustment. Because these models
are often ratio-based (e.g., logistic or Cox multiple
regression), reference in the paper to interaction with-
out specif ication of the interaction model often
means multiplicative interaction. However, regard-
less of the model chosen for adjustment, additive
interaction is important for public health pur-
poses,13,17 and can be readily assessed even in the
context of ratio-based models.19
A simple technique that is becoming increasingly
popular, and allows establishing the limits of the ac-
curacy of the inferences drawn by the authors is sen-
sitivity analysis, which is generally defined as “the
quantitative assessment of systematic error on an ef-
fect estimate”.9,* It is a tool to examine changes in
the output (results) of a given model resulting from
varying certain model parameters (or assumptions)
over a reasonable range.17 Use of this technique re-
flects the authors’ concerns with validity of their find-
ings, and thus it is looked upon favorably by journal
reviewers and editors.
Results
The presentation of results should go from the most
to the least parsimonious approaches. Thus, it is
strongly recommended that authors begin this sec-
tion with a presentation of frequency distributions,
means, medians. In observational studies the likeli-
hood of finding a real association is, among other
factors, a function of the variability of the factors
under study. Thus, authors should keep in mind the
possibility of systematically reporting coefficients
of variation (mean values divided by their standard
deviations) and/or inter-quartile ranges for key vari-
ables. The Results section should, in addition, include
a comparison between individuals included in the
study and those who, although eligible, refused in-
clusion. For prospective studies, at a minimum, a com-
parison between persons lost and those not lost to
observation with regard to baseline characteristics
should be provided.
Stratification allows both (partial) assessment of con-
founding and examination of heterogeneity (interac-
tion), and should generally follow the data presenta-
tion described in the previous paragraph. Following
stratification, results of regression methods should
be presented, if necessary. However, when reporting
these results in a table format, the authors should be
as reader-friendly as possible by:
1. presenting the most easily understandable figu-
*Sensitivity analysis can be also used to assess the impact of random errors. See, for example, Peppard et al.12
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res – e.g., odds ratios instead of regression
coefficient;
2. using stratification for reporting interac-
tions, and limiting the use of interaction
terms to statistical testing, as outside the
realm of prediction these terms are not
readily interpretable;
3. making sure that the titles of tables and
figures are so informative that their inter-
pretation does not require that the reader
consult the text;
4. specifying units for each variable entered in a
regression model (e.g., age in individual years or
age groups, smoking as current, former and never
smokers);
5. avoiding redundancy, such as for example report-
ing both p values and confidence intervals for a
given measure of association.
For figures, the most common mistake in papers sub-
mitted to the American Journal of Epidemiology is
the use of an arithmetic scale in the ordinate with a
reference of zero for plotting odds ratios or relative
risks. Because these measures of association are ra-
tios, a semi-log scale with a baseline of 1.0 should be
always used. However, the arithmetic scale can be
used when plotting the logarithms of these ratio-based
association measures.
Discussion
The Discussion section is where the authors have the
greatest latitude to speculate about the findings of
their study. The quality of a Discussion section de-
pends on how persuasive the authors’ arguments are
with regard to having proved or disproved the hy-
pothesis. There is no standard format for this section,
but in most published papers, the following sequence
is used by authors:
1. a brief review of the study findings (e.g., “In our
study, a relationship was found between x and y,
which could not be explained by the
effects of known confounders”;
2. a review of the pertinent literature, in which
the similarities and discrepancies between
the findings of the present study and those
of previous studies are highlighted;
3. a discussion of the strengths and limitat-
ions of the present study, and how future
studies can improve the methodology
and design needed to reach firmer conclu-
sions about the hypothesis;
4. if appropriate, provide a discussion of
policy implications. With regard to this
issue, caution is necessary because
translation of epidemiologic findings into
policy decisions – particularly as they relate to
primary prevention – requires that a cause-effect
relationship be established, which is impossible in
the context of a single observational study. Thus,
in reports of observational studies, the word “effect”
should be avoided (such as when stating that “the
effect of x on y was not changed by adjustment”);
instead, these reports should refer to associations
(which may or may not be causal).
The interpretation of p-values and 95% confidence
limits, which assist the authors in concluding
whether or not an association is a chance finding,
deserves special caution. Although informative,
these values should not be construed as rigid rules
on which to base definitive inferences. A hypotheti-
cal example would be a manuscript in which the
authors concluded that excessive alcohol consump-
tion is not associated with risk of causes other than
liver cirrhosis, on the basis of relative risk (RR) of
1.5 and a 95% confidence interval for the RR of 0.9,
2.6. This inference is not warranted, as the authors
overlooked the fact that the confidence interval func-
tion of the relative risk is not a straight line that is
parallel to the abscissa, but rather follows a
lognormal distribution (Figure 1). For this example,
most of the area under the curve is to the right of the
null hypothesis (Figure 2), thus suggesting that most
of the range of possible values support the presence
of an association (assuming no bias).
Figure 1 - Incorrect (A) and correct (B) interpretations of the 95%
confidence interval of a relative risk or an odds ratio.
A. Incorrect
Point Estimate
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Figure 2 - Correct inference when the relative risk is 1.5 and the 95%
confidence interval is 0.9, 2.6: there is an association, although the 95%
confidence interval overlaps the null value (OR=1.0).
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CONCLUSIONS
It is often difficult to judge the quality of a scientific
article. The peer review process has been the bedrock
of science, notwithstanding its flaws reflected by a
less-than-perfect reliability and an unknown valid-
ity. However, as it is likely that the peer review proc-
ess will continue to exist for years to come, authors
should be well advised to follow a few simple rules in
order to avoid a number of pitfalls when preparing a
manuscript. This paper tried to summarize these rules,
in the hopes that they could serve as guideposts for
potential authors. It should, however, be emphasized
that it is impossible to comment on all possible types
of papers, and consequently this article was limited
to a discussion of the kinds of challenges its author
has faced as editor-in-chief of the American Journal
of Epidemiology.
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